EVGN News
Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward
Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward PR Newswire REHOVOT, Israel, Aug. 31, 2026 Company urges shareholders to...
PR Newswire
Evogene (EVGN) Q2 2026 Earnings Call Transcript
Evogene (EVGN) Q2 2026 Earnings Call Transcript...
Yahoo! Finance: News
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director Nominees
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director Nominees Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of...
PR Newswire
Evogene Reports Second Quarter and First Half 2026 Financial Results
Evogene Reports Second Quarter and First Half 2026 Financial Results Evogene Reports Second Quarter and First Half 2026 Financial Results PR Newswire REHOVOT, Israel, Aug. 18, 2026 Company continues strategic transformation, initiated in 2025, into a focused, AI-driven computational chemistry...
PR Newswire
Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation
Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation PR Newswire REHOVOT, Israel, Aug. 14, 2026 Zoom conference call scheduled...
PR Newswire
Evogene Schedules Second Quarter 2026 Financial Results Release
Evogene Schedules Second Quarter 2026 Financial Results Release Evogene Schedules Second Quarter 2026 Financial Results Release PR Newswire REHOVOT, Israel, July 30, 2026 Zoom conference call scheduled for August 18, 2026, 9:00 AM ETREHOVOT, Israel, July 30, 2026 /PRNewswire/ -- Evogene Ltd...
PR Newswire
Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipidemia and Cardiovascular Diseases
Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipidemia and Cardiovascular Diseases Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for...
PR Newswire
AgPlenus Launches Novel AI Model for Predicting Antifungal Potency, Expanding ChemPass AI for Ag Capabilities
AgPlenus Launches Novel AI Model for Predicting Antifungal Potency, Expanding ChemPass AI for Ag Capabilities AgPlenus Launches Novel AI Model for Predicting Antifungal Potency, Expanding ChemPass AI for Ag Capabilities PR Newswire REHOVOT, Israel, July 15, 2026 New AI model enables ChemPass AI for...
PR Newswire
Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery
Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery...
PR Newswire
Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI Toward Autonomous Small Molecule Discovery and Optimization
Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI Toward Autonomous Small Molecule Discovery and Optimization Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI Toward Autonomous Small Molecule Discovery and...
PR Newswire